FdaApplication

NDA 218772

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSCIENTURE LLC
application_typeNDA
approval_date2025-03-13

Products (1)

ProductActive ingredientStrengthDosage form
ARBLILOSARTAN POTASSIUM10MG/MLSUSPENSION;ORAL

1 product